Publications by authors named "Ruby K Li"

Claim this Profile
P
Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma.
Joong-Won Park, Richard S Finn, Jun Suk Kim, Mark Karwal, Ruby K Li

Clin Cancer Resยท April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis